bg
A

AN2 Therapeutics (ANTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About AN2 Therapeutics (ANTX)

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more

  • USD17.19
  • USD17.19
  • USD16.28
  • USD17.75
  • 13.00%
  • --
  • 1.00
  • 48.90k
  • 513M
  • 4.87
  • 49.00%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.